A team of doctors led by Shailender Singh, an interventional cardiologist, and Dr AGK Gokhale, cardio-thoracic surgeon, have joined the Global Hospital from Mediciti Hospitals to offer the full-fledged services in the new division.
Global Hospitals is investing Rs 7-8 crore to install the state-of-the-art cardiac equipment to provide services to the cardiac patients, K Ravindranath, the managing director, told a press conference.
Funded by the union government’s Technology Development Board (TDB), Global Hospitals has so far invested about Rs 30 crore in operation theatres, intensive care units, transfusion facilities and other infrastructure to carry out liver, kidney and bone marrow transplantation.
“Global Hospitals’ built-in facilities and standard operating procedures (SOPs) to prvent infections, the most critical aspect in the transplantation, would be suited to perform heart transplantation surgeries. In fact, a hospital like this which is fully equipped to undertake multi-organ transplantation would be perfect place to do complicated cardiac surgeries,” said Shailender Singh.
“We will be soon visting a couple of centres involved in heart transplantation in Australia to have the required initial association with them. We hope to undertake first heart transplantation early next year, by which time all the prtocols will be in place,” said Gokhale, who was earlier associated with a heart transplantation centre in Australia.
Ghokale said that at present four centres including the All India Institute of Medical Sciences (AIIMS), New Delhi, were undertaking heart transplantation in the country and about 25-30 transplantations had been performed in the last four years after it was first carried out by All India Institute of Medical Sciences.
Patients with end-stage heart disease reflected by low cardiac output can undergo heart transplantation if a brain-dead patient’s relatives aggree to donate heart.
“Being a multi-organ tranplantation centre, we would like to take the lead in heart transplantation too in the state. We hope to produce results comparable to Western standards at reasonable cost,” Ravindranath said.